This firm-fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Auburn University, a public land-grant research university, to conduct an OPIOID REPORT/STUDY. The award, valued at $124,882.00, was made under the CDC's sole source justification in accordance with Federal Acquisition Regulation (FAR) 6.302-1, as Auburn University had developed a unique methodology for the rapid and efficient detection of fentanyl analogues. The contract does not have a set-aside designation. Auburn University, through its prime and sub-federal contracts, has provided a range of research, engineering, testing, and consulting services to various federal agencies.